Pathology EMQ template.

Name: Alice Johnston

Candidate number:

Theme:

OPTION LIST

A	Azathioprine	I	Methotrexate
B	Basiliximab	J	Mycophenolate mofetil
C	Chlorambucil	K	Plasmapheresis
D	Ciclosporin	L	Recombinant cytokines
E	Corticosteroids	M
F	Cyclophoshamide	N
G	Infliximab	O
H	Intravenous immunoglobulin	P

For each scenario below, choose the most appropriate answer from the list above. Each option may be used once, more than once or not at all.

1. Requires therapeutic monitoring as risk of bone marrow suppression.

2. An inhibitor of T-cell signalling associated with nephrotoxicity.

3. An anti-cytokine agent.

4. Useful in the treatment of congenital aggammaglobulinaemia.

5. Indicated in the treatment of multi-system connective tissue disease with end-organ involvement.

ANSWERS

1. A

2. D

3. G

4. H

5. F